Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000793978 | SCV000933360 | benign | Nemaline myopathy 2 | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004027465 | SCV004980595 | uncertain significance | Inborn genetic diseases | 2023-10-10 | criteria provided, single submitter | clinical testing | The c.6968G>A (p.R2323Q) alteration is located in exon 53 (coding exon 51) of the NEB gene. This alteration results from a G to A substitution at nucleotide position 6968, causing the arginine (R) at amino acid position 2323 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV000793978 | SCV001461126 | uncertain significance | Nemaline myopathy 2 | 2020-01-24 | no assertion criteria provided | clinical testing |